Haemonetics Scheduled to Report Q2 2027 Earnings on November 5
Haemonetics (HAE) is set to release its second-quarter fiscal 2027 earnings report on Thursday, November 5, prior to the market opening. Financial analysts are looking for steady growth in both top and bottom lines compared to the previous year. The consensus estimates project an earnings per share (EPS) of $1.29, representing a 1.6% increase year-over-year. Revenue is expected to reach approximately $345.15 million, which would mark a 5.6% increase compared to the same period last year.
Tickers: $HAE